Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Corporate Action
Jagsonpal Pharmaceuticals announced the allotment of 296,320 equity shares of Rs 2 each under its Employee Stock Option Plan 2022, increasing paid-up capital from Rs 13.10783 crore to Rs 13.167094 crore and total shares from 65,539,150 to 65,835,470, with shares ranking pari passu with existing shares.
About Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when JAGSNPHARM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track JAGSNPHARM — Free💡 Ask AI about this filing
📊 More JAGSNPHARM filings
- 🔴 Corporate Action — 15 July 2026 Jagsonpal Pharmaceuticals announced the allotment of 94,000 equity shares of Rs. 2 each under its Em...
- Announcement — 8 July 2026 Jagsonpal Pharmaceuticals announced completion of acquiring 77.21% equity in Aequitas Healthcare, fa...
- share transfer — 6 July 2026 Jagsonpal Pharmaceuticals received a SEBI-mandated certificate from MCS Share Transfer Agent confirm...
- regulation 31 — 30 June 2026 Jagsonpal Pharmaceuticals disclosed promoter shareholding details as of March 31, 2026 under SEBI Re...
- Announcement — 29 June 2026 Jagsonpal Pharmaceuticals announced it will acquire an 85% stake in Aequitas Healthcare Private Limi...
🔥 Also filed on 4 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when JAGSNPHARM files new disclosures
Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track JAGSNPHARM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research